NCT01453478View on ClinicalTrials.gov

A Study to Look at How GSK1325756 is Taken up by the Body When Given by Mouth When Stomach Acid is Reduced

PHASE1CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

October 12, 2011

Primary Completion Date

December 19, 2011

Study Completion Date

December 19, 2011

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

GSK1325756

CXCR2 antagonist

Trial Locations (1)

NG11 6JS

GSK Investigational Site, Nottingham

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01453478 - A Study to Look at How GSK1325756 is Taken up by the Body When Given by Mouth When Stomach Acid is Reduced | Biotech Hunter | Biotech Hunter